CN1032785A - L-二羟基苯丙氨酸衍生物或其酸加成盐、其生产方法及其用途 - Google Patents

L-二羟基苯丙氨酸衍生物或其酸加成盐、其生产方法及其用途 Download PDF

Info

Publication number
CN1032785A
CN1032785A CN88107165A CN88107165A CN1032785A CN 1032785 A CN1032785 A CN 1032785A CN 88107165 A CN88107165 A CN 88107165A CN 88107165 A CN88107165 A CN 88107165A CN 1032785 A CN1032785 A CN 1032785A
Authority
CN
China
Prior art keywords
dopa
acid salt
formula
derivative
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN88107165A
Other languages
English (en)
Chinese (zh)
Inventor
土屋义己
林正弘
竹花博
樋板章博
沢崎芳男
伊原正树
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of CN1032785A publication Critical patent/CN1032785A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN88107165A 1987-09-18 1988-09-17 L-二羟基苯丙氨酸衍生物或其酸加成盐、其生产方法及其用途 Pending CN1032785A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP234,299/87 1987-09-18
JP23429987 1987-09-18
JP3126088 1988-02-13
JP31,260/88 1988-02-13

Publications (1)

Publication Number Publication Date
CN1032785A true CN1032785A (zh) 1989-05-10

Family

ID=26369718

Family Applications (1)

Application Number Title Priority Date Filing Date
CN88107165A Pending CN1032785A (zh) 1987-09-18 1988-09-17 L-二羟基苯丙氨酸衍生物或其酸加成盐、其生产方法及其用途

Country Status (12)

Country Link
US (1) US4966915A (enExample)
EP (1) EP0309827B1 (enExample)
JP (1) JPH02138A (enExample)
KR (1) KR890005031A (enExample)
CN (1) CN1032785A (enExample)
AT (1) ATE71083T1 (enExample)
AU (1) AU2234088A (enExample)
CA (1) CA1316180C (enExample)
DE (1) DE3867403D1 (enExample)
DK (1) DK517588A (enExample)
IL (1) IL87765A0 (enExample)
PT (1) PT88526B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102224131B (zh) * 2008-11-10 2013-11-06 韩国海洋研究院 化合物ramalin及其应用
CN103694127A (zh) * 2013-12-30 2014-04-02 上海交通大学 链霉菌属菌种所产的化合物及该化合物的制备方法和应用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1480647T3 (da) * 2002-02-15 2009-01-26 Darpharma Inc Mono-ester eller asymmetrisk substituerede di-ester-prodrugs af dopamin-D1 receptoragonister
US7101912B2 (en) 2002-12-06 2006-09-05 Xenoport, Inc. Carbidopa prodrugs and derivatives, and compositions and uses thereof
US6970629B2 (en) 2002-12-19 2005-11-29 Corning Cable Systems Llc Optical tube assembly having a dry insert and methods of making the same
US20090190890A1 (en) 2002-12-19 2009-07-30 Freeland Riley S Fiber optic cable having a dry insert and methods of making the same
US7471862B2 (en) 2002-12-19 2008-12-30 Corning Cable Systems, Llc Dry fiber optic cables and assemblies
IL154318A (en) 2003-02-06 2010-05-31 Sarah Herzog Memorial Hospital Pharmaceutical compositions for the treatment of movement disorders
WO2005121070A1 (en) 2004-06-04 2005-12-22 Xenoport, Inc. Levodopa prodrugs, and compositions and uses thereof
PT1751087E (pt) * 2004-06-04 2012-09-10 Xenoport Inc Derivados de levodopa e as suas composições e utilizações
CN101365439B (zh) 2005-12-05 2012-12-26 克塞诺波特公司 左旋多巴前体药物甲磺酸盐、其组合物及其用途
TW200843731A (en) 2006-12-21 2008-11-16 Xenoport Inc Catechol protected levodopa diester prodrugs, compositions, and methods of use
US7709527B2 (en) * 2006-12-21 2010-05-04 Xenoport, Inc. Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use
JP2012505885A (ja) * 2008-10-20 2012-03-08 ゼノポート，インコーポレーテッド レボドパエステルプロドラッグを合成する方法
US8399513B2 (en) * 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
WO2011056240A2 (en) 2009-11-09 2011-05-12 Xenoport, Inc. Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
WO2011107653A2 (en) 2010-03-04 2011-09-09 Orion Corporation Method for treating parkinson's disease
JP6567049B2 (ja) 2014-10-21 2019-08-28 アッヴィ・インコーポレイテッド カルビドパおよびｌ−ドーパプロドラッグならびにそれらの使用方法
AU2016258179B2 (en) 2015-05-06 2021-07-01 Synagile Corporation Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
WO2019097120A1 (en) 2017-11-16 2019-05-23 Orion Corporation New use and pharmaceutical dosage forms
CA3117983A1 (en) 2018-11-15 2020-05-22 Abbvie Inc. Pharmaceutical formulations for subcutaneous administration
US20220213128A1 (en) * 2021-01-03 2022-07-07 RockGen Therapeutics LLC L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease
US20240415800A1 (en) * 2021-10-11 2024-12-19 The Johns Hopkins University Dopa and caffeic acid analogs as novel gcpii inhibitors
WO2025075499A1 (en) 2023-10-02 2025-04-10 Universiteit Van Amsterdam Reducing dopamine feed-back inhibition in dopaminergic cells by tadalafil.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393923A (en) * 1888-12-04 Samuel preston
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
US3725470A (en) * 1969-05-14 1973-04-03 Hoffmann La Roche Amino acid derivatives
CH562199A5 (enExample) * 1970-10-30 1975-05-30 Hoffmann La Roche
BE793426A (fr) * 1971-12-28 1973-06-28 Lannacher Heilmittel G M B H Derives de phenylalanine
US3983138A (en) * 1973-09-25 1976-09-28 Merck & Co., Inc. Amino acid esters
US3939253A (en) * 1973-11-02 1976-02-17 Interx Research Corporation Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa
US4401676A (en) * 1977-06-01 1983-08-30 Merck & Co., Inc. Novel α-amino acids
US4311706A (en) * 1980-01-22 1982-01-19 Interx Research Corporation Novel dopa/dopamine prodrugs

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102224131B (zh) * 2008-11-10 2013-11-06 韩国海洋研究院 化合物ramalin及其应用
CN103694127A (zh) * 2013-12-30 2014-04-02 上海交通大学 链霉菌属菌种所产的化合物及该化合物的制备方法和应用

Also Published As

Publication number Publication date
ATE71083T1 (de) 1992-01-15
DE3867403D1 (de) 1992-02-13
KR890005031A (ko) 1989-05-11
DK517588A (da) 1989-03-19
JPH0541626B2 (enExample) 1993-06-24
CA1316180C (en) 1993-04-13
DK517588D0 (da) 1988-09-16
AU2234088A (en) 1989-03-23
JPH02138A (ja) 1990-01-05
PT88526A (pt) 1988-10-01
EP0309827A1 (en) 1989-04-05
US4966915A (en) 1990-10-30
PT88526B (pt) 1992-11-30
EP0309827B1 (en) 1992-01-02
IL87765A0 (en) 1989-02-28

Similar Documents

Publication Publication Date Title
CN1032785A (zh) L-二羟基苯丙氨酸衍生物或其酸加成盐、其生产方法及其用途
CN1037439C (zh) 制备具有神经保护作用的吲哚酮及有关衍生物的方法
CN1028104C (zh) 制备喹诺酮衍生物的方法
CN1028992C (zh) 1，4，-苯并硫杂吖庚因衍生物的制备方法
US5698527A (en) Steroidal glycosides as antihyperlipidemic agents
JP2019052152A (ja) トレプロスチニルの塩
SA08280756B1 (ar) معضدات gpcr تشتمل على بروبوكسى بنزاميد وبيوتوكسى بنزاميد
CN1533270A (zh) 具有降低毒性的gaba类似物前药的口服给药剂型
CN1438220A (zh) 1－（1，2－双取代哌啶基〕－4－取代哌嗪衍生物
CN86107627A (zh) 新颖的4-苄基-1-(2h)-酞嗪酮衍生物的制备方法
CN1217720A (zh) 苯并呋喃基衍生物及其应用
JP5833143B2 (ja) フェニル−イソオキサゾール誘導体およびその製造方法
CN1147297C (zh) 新型七叶亭衍生物及医药组合物
CN1675193A (zh) 1－甲基－2－(4－脒基苯基氨甲基)－苯并咪唑－5－基－羧酸－(n－2－吡啶基－n－2－羟基羰基乙基－酰胺的新颖前药，其制法及其作为药物制剂的用途
CN1202167A (zh) 兴奋性的氨基酸衍生物
WO2008062830A1 (en) Spiroquinone compound and pharmaceutical composition
MX2009001852A (es) Sintesis, polimorfos, y formulacion farmaceutica de un inhibidor de faah.
CN1468219A (zh) 哌啶衍生物及含这些衍生物作为有效成分的药物
US10538507B2 (en) Preparation process for high-purity dabigatran etexilate
CN1065241C (zh) 在7位上用氟取代的2,3－二脱氢唾液酸及其合成中间体
CN1247528A (zh) 环戊烯酮衍生物
CN1886371A (zh) 氟伐他汀钠多晶型物的制备方法
MC1357A1 (fr) Derives de 2,3-indoledione
CN1278821A (zh) 作为中性白细胞弹性蛋白酶抑制剂的吡咯并吡咯酮衍生物
US20110112145A1 (en) Salts Of Methyl 2-((R))-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3((R)-tetrahydro-2H-Pyran-3-YL)Propylcarbamoyl)Piperidin-3-YL)Methoxy)Ethylcarbamate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication